Andreas Kalogeropoulos MD, MPH, PhDAssistant Professor, Department of Medicine, Division of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University, Atlanta, GA
Andreas Kalogeropoulos, MD MPH PhD, is an Assistant Professor in the Department of Medicine, Division of Cardiology, and the Emory Clinical Cardiovascular Research Institute at Emory University, Atlanta, GA. He is a clinical and outcomes researcher in cardiovascular medicine with expertise in heart failure, echocardiography, and methods in research. He trained in medicine and cardiology at the University of Patras, Greece, and in echocardiography, heart failure, and outcomes research at Emory University. He has authored or co-authored over 130 articles in peer-reviewed journals and two book chapters. He has received research support from the Atlanta Clinical and Translational Science Institute, the American Heart Association, the American Society of Echocardiography, and the Centers for Disease Control and Prevention for his work on myocardial deformation imaging, heart failure, and adult congenital heart disease. He serves on the Editorial Boards of the Journal of American Society of Echocardiography and the Journal of Cardiac Failure, the Research Committees of the American Society of Echocardiography and the Heart Failure Society of America, the National Cardiovascular Data Registry ICD Registry Publications and Presentations Subcommittee, and other institutional and international scientific boards. He is the recipient of an American Heart Association Scientist Development Grant (National Affiliate) and an investigator of the NIH Heart Failure Network. His research focuses on (1) risk factors for incident heart failure at the population level; (2) risk factors, outcomes, and clinical prediction models for patients with advanced heart failure; and (3) applications of contemporary echocardiography for advanced heart failure and congenital heart disease.
Currently, Dr. Kalogeropoulos receives research support from the NIH (NHLBI, NIA, and the NIH-supported Atlanta Clinical & Translational Science Institute [ACTSI]), the American Heart Association, and the Centers for Disease Control and Prevention (CDC). There are no other relevant disclosures or CoI.